Hit-to-lead optimization of amino-carboxamide benzothiazoles as LSD1 inhibitors

被引：0

作者：

Du’a Al bustanji

Soraya Alnabulsi

Enas A. Al-Hurani

机构：

[1] Jordan University of Science and Technology,Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy

[2] P.O. Box 3030,undefined

来源：

Medicinal Chemistry Research | 2023年 / 32卷

关键词：

LSD1 enzyme; hit-to-lead optimization; anticancer; structure-activity relationship; amino-carboxamide benzothiazoles.;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：910 / 929

页数：19

共 50 条

[21] Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1
Dai, Xing-Jie
Liu, Ying
Xue, Lei-Peng
Xiong, Xiao-Peng
Zhou, Ying
Zheng, Yi-Chao
Liu, Hong-Min
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (05) : 2466 - 2488
[22] Phenocopy - A Strategy to Qualify Chemical Compounds during Hit-to-Lead and/or Lead Optimization
Baum, Patrick
Schmid, Ramona
Ittrich, Carina
Rust, Werner
Fundel-Clemens, Katrin
Siewert, Susanne
Baur, Martin
Mara, Lisa
Gruenbaum, Lore
Heckel, Armin
Eils, Roland
Kontermann, Roland E.
Roth, Gerald J.
Gantner, Florian
Schnapp, Andreas
Park, John E.
Weith, Andreas
Quast, Karsten
Mennerich, Detlev
PLOS ONE, 2010, 5 (12): : 1 - 15
[23] Small molecule inhibitors of Mdm2 as novel cancer therapeutics: From hit-to-lead generation to lead optimization
Kim, K
Liu, E
Mischke, SG
Schutt, A
Vassilev, LT
Wang, BB
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2699 - U2700
[24] Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors
Kuhnert, Maren
Koester, Helene
Bartholomaeus, Ruben
Park, Ah Young
Shahim, Amir
Heine, Andreas
Steuber, Holger
Klebe, Gerhard
Diederich, Wibke E.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (09) : 2849 - 2853
[25] Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors
Gehling, Victor S.
Mcgrath, John P.
Duplessis, Martin
Khanna, Avinash
Brucelle, Francois
Vaswani, Rishi G.
Cote, Alexandre
Stuckey, Jacob
Watson, Venita
Cummings, Richard T.
Balasubramanian, Srividya
Iyer, Priya
Sawant, Priyanka
Good, Andrew C.
Albrecht, Brian K.
Harmange, Jean-Christophe
Audia, James E.
Bellon, Steven F.
Trojer, Patrick
Levell, Julian R.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (06): : 1213 - 1220
[26] Dual inhibitors of LSD1 and spermine oxidase
Holshouser, Steven
Dunworth, Matthew
Murray-Stewart, Tracy
Peterson, Yuri K.
Burger, Pieter
Kirkpatrick, Joy
Chen, Huan-Huan
Casero, Robert A., Jr.
Woster, Patrick M.
MEDCHEMCOMM, 2019, 10 (05) : 778 - 790
[27] Discovery of potent reversible inhibitors of LSD1
Chen, Young
Kanouni, Toufike
Severin, Christophe
Xu, Jiangchun
Del Rosario, Joselyn
Shi, Lihong
Lai, Chon
Stafford, Jeffrey
Veal, Jim
Stansfield, Ryan
Cho, Rob
Yuen, Natalie
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[28] Trends of LSD1 inhibitors in viral infections
Zwergel, Clemens
Stazi, Giulia
Mai, Antonello
Valente, Sergio
FUTURE MEDICINAL CHEMISTRY, 2018, 10 (10) : 1133 - 1136
[29] Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors
Dinges, Jurgen
Akritopoulou-Zanze, Irini
Arnold, Lee D.
Barlozzari, Teresa
Bousquet, Peter F.
Cunha, George A.
Ericsson, Anna M.
Iwasaki, Nobuhiko
Michaelides, Michael R.
Ogawa, Nobuo
Phelan, Kathleen M.
Rafferty, Paul
Sowin, Thomas J.
Stewart, Kent D.
Tokuyama, Ryukou
Xia, Zhiren
Zhang, Henry Q.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4371 - 4375
[30] Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors
Snow, Roger J.
Abeywardane, Asitha
Campbell, Scot
Lord, John
Kashem, Mohammed A.
Khine, Hnin Hnin
King, Josephine
Kowalski, Jennifer A.
Pullen, Steven S.
Roma, Teresa
Roth, Gregory P.
Sarko, Christopher R.
Wilson, Noel S.
Winters, Michael P.
Wolak, John P.
Cywin, Charles L.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3660 - 3665

← 1 2 3 4 5 →